Related Experiment Video
Updated: May 22, 2026
07:39
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Phages and HIV-1: from display to interplay
Sylvie Delhalle1, Jean-Claude Schmit1,2, Andy Chevigné1
1Laboratory of Retrovirology, CRP-Sante, 84, Val Fleuri, L-1526 Luxembourg, Luxembourg.
International Journal of Molecular Sciences
|May 19, 2012
Summary
Phage display technology has been crucial in understanding human immunodeficiency virus type 1 (HIV-1) by identifying antibody targets and potential inhibitors, aiding vaccine and drug development.
Area of Science:
- Immunology
- Virology
- Biotechnology
Background:
- Human immunodeficiency virus type 1 (HIV-1) presents challenges for vaccine development due to its complex interaction with the host immune system.
- The high genetic variability of HIV-1 hinders effective long-term control through antiviral drugs.
Purpose of the Study:
- To review the diverse applications of phage display technology in HIV-1 research.
- To summarize studies focusing on phage libraries, target display, and biopanning procedures for HIV-1.
- To highlight the role of phage display in identifying epitopes and inhibitors.
Main Methods:
- Phage display technology has been employed for over two decades in HIV-1 research.
- Biopanning experiments utilized combinatorial libraries and antibody fragments against viral targets and host receptors.
- Phage particles were used as carriers for displaying HIV-1 antigens.
Main Results:
- Phage display has elucidated the epitope landscape recognized by HIV-1-specific antibodies, identifying immunodominant and neutralizing epitopes.
- Biopanning identified potential HIV-1 inhibitors by targeting viral components and host cell receptors.
- The enzymatic specificity of HIV-1 protease has been characterized using phage display.
- Phage particles effectively presented HIV-1 antigens to elicit immune responses.
Conclusions:
- Phage display technology is a versatile tool in HIV-1 research, contributing significantly to understanding viral epitopes and developing inhibitors.
- This technology aids in the exploration of antibody-antigen interactions and the discovery of novel therapeutic strategies against HIV-1.
- Phage display offers a valuable platform for HIV-1 vaccine and drug discovery efforts.
More Related Videos
Related Concept Videos
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
00:43Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
01:26DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...